Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
Inv. presentation
|
|
Annexon, Inc. (ANNX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| Dananberg Jamie (Chief Medical Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 275,000 options to buy
@ $3.54, valued at
$973.5k
|
|
| 06/12/2023 |
4
| Satter Muneer A (10% Owner) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 06/12/2023 |
4
| WIGGANS THOMAS G (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 06/12/2023 |
4
| Choi Jung (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 06/12/2023 |
4
| Cockroft Bettina M. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 06/12/2023 |
4
| Waddill William D. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 06/12/2023 |
4
| Carson William H. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $2.88, valued at
$69.1k
|
|
| 05/30/2023 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Annexon, Inc.|
Txns:
| Bought 300,000 shares
@ $2.1324, valued at
$639.7k
|
|
| 02/21/2023 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 345,000 options to buy
@ $5.94, valued at
$2M
|
|
| 02/21/2023 |
4
| Overdorf Michael (EVP & Chief Business Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 18,975 shares
@ $0
Granted 77,050 options to buy
@ $5.94, valued at
$457.7k
|
|
| 02/21/2023 |
4
| Lew Jennifer (EVP & CFO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 18,975 shares
@ $0
Granted 77,050 options to buy
@ $5.94, valued at
$457.7k
|
|
| 01/18/2023 |
4
| ARTIS DEAN RICHARD (EVP & Chief Scientific Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 210,000 options to buy
@ $6.84, valued at
$1.4M
|
|
| 07/13/2022 |
4
| Overdorf Michael (EVP & Chief Business Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 9,375 shares
@ $0
Granted 75,000 options to buy
@ $3.91, valued at
$293.3k
|
|
| 07/13/2022 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.91, valued at
$1.2M
|
|
| 07/13/2022 |
4
| Mattheakis Larry (EVP & Chief Scientific Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 4,688 shares
@ $0
Granted 37,500 options to buy
@ $3.91, valued at
$146.6k
|
|
| 07/13/2022 |
4
| Mattheakis Larry (EVP & Chief Scientific Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 4,688 shares
@ $0
Granted 37,500 options to buy
@ $3.91, valued at
$146.6k
|
|
| 07/13/2022 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.91, valued at
$1.2M
|
|
| 07/13/2022 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.91, valued at
$1.2M
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Cockroft Bettina M. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $3.84, valued at
$92.2k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Carson William H. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 24,000 options to buy
@ $3.84, valued at
$92.2k
|
|
| 04/18/2022 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Bought 60,000 shares
@ $2.4469, valued at
$146.8k
|
|
| 02/15/2022 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 320,000 options to buy
@ $6.94, valued at
$2.2M
|
|
| 02/15/2022 |
4
| Overdorf Michael (EVP & Chief Business Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 100,000 options to buy
@ $6.94, valued at
$694k
|
|
| 02/15/2022 |
4
| Keswani Sanjay (EVP & Chief Medical Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 100,000 options to buy
@ $6.94, valued at
$694k
|
|
| 02/15/2022 |
4
| Lew Jennifer (EVP & CFO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 100,000 options to buy
@ $6.94, valued at
$694k
|
|
| 02/15/2022 |
4
| Mattheakis Larry (EVP & Chief Scientific Officer) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 100,000 options to buy
@ $6.94, valued at
$694k
|
|
| 01/20/2022 |
4
| Cockroft Bettina M. (Director) has filed a Form 4 on Annexon, Inc.|
Txns:
| Granted 20,000 options to buy
@ $8.08, valued at
$161.6k
|
|
| 11/15/2021 |
4
| Love Douglas (President & CEO) has filed a Form 4 on Annexon, Inc.|
Txns:
| Exercised 70,942 options to buy
@ $1.4096, valued at
$100k
Exercised 30,000 options to buy
@ $1.8501, valued at
$55.5k
|
|
|
|
|